MCD
52
3
NWSA
69
4
CHRW
53
2
MTB
38
4
HSIC
42
2
OKE
61
2
MKC
54
3
WMB
58
3
V
70
14
BDX
59
3
SWK
53
4
ITW
45
2
CMCSA
49
3
WM
53
2
INTU
54
2
KIM
58
2
MA
60
5
XRX
48
2
MAS
46
3
PDCO
77
3
MCD
52
3
NWSA
69
4
CHRW
53
2
MTB
38
4
HSIC
42
2
OKE
61
2
MKC
54
3
WMB
58
3
V
70
14
BDX
59
3
SWK
53
4
ITW
45
2
CMCSA
49
3
WM
53
2
INTU
54
2
KIM
58
2
MA
60
5
XRX
48
2
MAS
46
3
PDCO
77
3
Financhill
Back

Global X Adaptive US Factor ETF Vs. Novo Nordisk AS Industry Stock Comparison

Sell
24

AUSF
Global X Adaptive US Factor ETF

Last Price:
$42.29
Seasonality Move:
-3.12%
Sell
23

NVO
Novo Nordisk AS

Last Price:
$85.00
Seasonality Move:
6.92%
Sell
24
Global X Adaptive US Factor ETF (AUSF) is a Sell

Is Global X Adaptive US Factor ETF a Buy, Sell or Hold?

  • The current Global X Adaptive US Factor ETF [AUSF] share price is $42.24. The Score for AUSF is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
  • AUSF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
23
Novo Nordisk AS (NVO) is a Sell

Is Novo Nordisk AS a Buy, Sell or Hold?

  • The current Novo Nordisk AS [NVO] share price is $85.00. The Score for NVO is 23, which is 54% below its historic median score of 50, and infers higher risk than normal.
  • NVO is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

AUSF Stock Price Chart

What is Global X Adaptive US Factor ETF's stock price today?

  • The Global X Adaptive US Factor ETF share price today is $42.24
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and AUSF is experiencing slight buying pressure.

NVO Stock Price Chart

What is Novo Nordisk AS's stock price today?

  • The Novo Nordisk AS share price today is $85.00
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NVO is experiencing slight buying pressure.

AUSF Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.4 Sell
Relative Strength Index (14 RSI): 33.53 Sell
Chaikin Money Flow: 5750 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (42.91 - 44.73) Sell
Bollinger Bands (100): (41.36 - 43.9) Sell

NVO Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -2.5 Sell
Relative Strength Index (14 RSI): 19.69 Sell
Chaikin Money Flow: 20899665 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (100.63 - 110.99) Sell
Bollinger Bands (100): (107.27 - 131.41) Sell

AUSF Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.89 Sell
20-day SMA: 43.89 Sell
50-day SMA: 43.61 Sell
200-day SMA: 41.29 Buy
8-day EMA: 42.75 Sell
20-day EMA: 43.37 Sell
50-day EMA: 43.36 Sell
200-day EMA: 41.14 Buy

NVO Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 104.71 Sell
20-day SMA: 106.65 Sell
50-day SMA: 109.28 Sell
200-day SMA: 126.25 Sell
8-day EMA: 102.07 Sell
20-day EMA: 105.53 Sell
50-day EMA: 110.02 Sell
200-day EMA: 118.09 Sell

Global X Adaptive US Factor ETF Earnings Growth & AUSF Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Novo Nordisk AS Earnings Growth & NVO Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.49 per share, and an increase next year of $0.72 per share.

Global X Adaptive US Factor ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Novo Nordisk AS Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):